H. Lundbeck A/S

In News

H. Lundbeck A/S: Lundbeck announces positive phase IIb top-line results with bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention - Finansavisen

Finansavisen - Feb 12, 2026

H. Lundbeck A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st

simplywall.st - Feb 07, 2026

H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal - The Wall Street Journal

The Wall Street Journal - Nov 14, 2025

Alkermes responds to potential rival bid for Avadel from Lundbeck - Investing.com

Investing.com - Nov 14, 2025

Lundbeck and Contera Pharma partner in neurological disorders - bioworld.com

bioworld.com - Oct 21, 2025

Lundbeck inks licence option deal with Contera Pharma - European Biotechnology Magazine

European Biotechnology Magazine - Oct 20, 2025

Avadel Pharmaceuticals agrees to sweetened $2.37B takeover bid from Alkermes amid bidding war - The Business Journals

The Business Journals - Nov 19, 2025

Novo Nordisk’s Miriam Frieden to lead BD at Lundbeck - biocentury.com

biocentury.com - Dec 02, 2025

Denmark Pharmaceutical Market Forecast and Company Analysis - GlobeNewswire

GlobeNewswire - Aug 05, 2025

H. Lundbeck A/S: Record 2025 performance with revenue up 13% CER and adjusted EBITDA up 24% CER positions Lundbeck for continued growth in 2026 - Finansavisen

Finansavisen - Feb 04, 2026

Denmark's Lundbeck bets on epilepsy drug with $2.6 bln Longboard deal - Reuters

Reuters - Oct 14, 2024

Zuellig Pharma expands partnership with Lundbeck to support commercialization of neuro-psychiatric health solutions in Asia - Sin Chew Daily

Sin Chew Daily - Dec 16, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment